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INTRODUCTION:  Aeromonas  are  Gram-negative  bacilli  often  causing  necrotizing  fasciitis  or sepsis  in
immunocompromised  patients.  Aeromonas  Hydrophila  is most  often  found  in immunocompromised
patients  or  those  with  burns  or aquatic  trauma.  When  patients  present  with  a  discharge  and  infection  on
bone  graft  donor  site  and  progressive  sepsis,  an  Aeromonas  hydrophila  infection  should  be considered  in
the differential  diagnosis.
PRESENTATION  OF  CASE:  We  report  here  a rare  case  of Aeromonas  hydrophila  with  surgical  site  sep-
sis/infection  in an  immunocompromised  69 years  old  female,  with  several  comorbids.  Here  we  are
reporting  infection  on donor  surgical  graft site,  sparing  major  surgical  site with  the implant.  After  getting
culture  report  of  exudates  from  the  wound  that  grew  A.  hydrophila,  immediate  wound  debridement  and
antibiotic  beads  insertion  was  performed  with  appropriate  antimicrobial  therapy  and regular  wound
dressing.  She was followed  for  around  2 years.
DISCUSSION: This  is  the  ﬁrst  report  to our  knowledge  of  A. Hydrophila  infection  in  bone  graft  donor
site.  Aeromonas  most  often  cause  gastrointestinal  and  soft  tissue  infections,  and  bacteremia  in immuno-
compromised  patients.  Early  surgical  intervention  is essential  to reducing  mortality  in deep  soft  tissue
infections  caused  by  this  organism.  Aeromonas  have  shown  resistance  to penicillin  but  are  sensitive  to
other  broad-spectrum  antibiotics.
CONCLUSION:  Early  suspicion,  diagnosis,  and  treatment  with  potent  antibiotics  are  needed  to  prevent  any
further  complications  resulting  from  infection  by  this  emerging  aggressive  pathogen.
©  2018  The  Author(s).  Published  by Elsevier  Ltd.  on behalf  of  IJS  Publishing  Group  Ltd.  This  is  an  open
access  article  under  the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Aeromonas species are Gram-negative bacilli that thrive in
aquatic environments, but may  be found in nearly all other envi-
ronmental settings, except in extreme conditions [1].
They cause necrotizing fasciitis and sepsis in patients with hep-
atic diseases, diabetes mellitus, and immunocompromised status
[1–4]. Most severe soft tissue infections reported, have been caused
by Aeromonas hydrophila [5–7].
Until recently, A. hydrophila was believed to be mainly a
marine and amphibian pathogenic organism [1]. However, these
∗ Corresponding author at: Section of Orthopedics, Department of Surgery, Aga
Khan University, P.O. Box 3500, Stadium Road, Karachi 74800, Pakistan.
E-mail addresses: obada.husseinali@aku.edu (O. Hasan),
wajiha.altaf92@gmail.com (W.  Khan), the.dermatologist86@gmail.com (M.  Jessar),
alyzaheer@gmail.com (A.Z. Pathan), riaz.lakdawala@aku.edu (R.H. Lakdawala).
organisms can act as primary pathogens in human hosts. Few
reports have been published of A. hydrophila infections result-
ing from nonaquatic injuries in healthy patients [8–10]. Typically,
patients who contract A. hydrophila are immunocompromised or
have sustained burns or trauma in an aquatic environment [1,2,6,7].
In the case of rapidly developing soft tissue infections, A.
hydrophila may  be considered by surgeons as a pathogen in
immunocompromised patients [7].
The aim of this case report was to show a rare organism that can
cause infection on bone graft donor site and management of that
infection in the best possible way by antibiotic beads insertion.
Our case report has been reported in line with SCARE criteria
[11].
2. Presentation of case
A 69 years old female with limited-community ambulation pre-
sented to our clinic with history of open reduction internal ﬁxation
https://doi.org/10.1016/j.ijscr.2018.08.037
2210-2612/© 2018 The Author(s). Published by Elsevier Ltd. on behalf of IJS Publishing Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Post Antibiotics beads x-ray showing the beads in right iliac region and bone graft at fracture site.
of her distal femur following a ground level fall 5 months back.
Since then she was unable to bear weight with tenderness on her
right thigh and knee. Scar was healthy and there was no wound
discharge. X-ray showed a broken plate with atrophic non-union
of distal femur shaft.
History revealed she had insulin dependent diabetes melli-
tus, hypertension, ischemic heart disease, chronic kidney disease,
restrictive airway disease, osteoporosis, and hepatitis C (treated).
She is obese with BMI  31.
Urine detailed report was positive for nitrites, more than 20
leukocytes/HPF and numerous bacteria. Urine culture showed E. coli
sensitive to Augmentin, Piperacillin-tazobactam and Gentamycin.
CRP and ESR levels were high (7 mg/dL and 52 mm/1st hour, respec-
tively). Following discussion and approval fromthe infectious
disease team she was kept on intravenous piperacillin-tazobactam
from admission. The next day she underwent removal of implant
and Intramedullary Nailing with autologous bone graft from iliac
crest and Bone Morphogenetic Protein (BMP) insertion. Culture
taken from the fracture site showed no growth of organisms.
Dressing was  done on 5th postoperative day (POD). Postopera-
tive rehabilitation started as per hospital protocol included chest,
ankle pumping and quadriceps isometric physiotherapy. Consid-
ering her BMI  and the co-morbids the surgeon advised her bed to
chair non-weight bearing ambulation on the operated side. Post-
operative stay was uneventful, and the wound remained dry, clean
and healthy. She was discharged from hospital in satisfactory con-
dition on 10th POD on oral Augmentin, analgesics and aspirin for
7 days and was called for follow up within a week. Stiches were
removed 2 weeks post-surgery and the wound looked healthy.
The patient returned to emergency department after a week
and reported swelling and discharge at right iliac crest bone graft
donor site. Wound scar looked healthy with minimal swelling
and tenderness at right iliac fossa. Emergent surgical debridement
and hematoma evacuation were performed, and broad-spectrum
intravenous antibiotics were started (gentamycin). Intraoperative
cultures showed no growth and the patient was discharged. She
was advised weight bearing as tolerated with support (walker).
Three weeks following her second surgery she was admit-
ted with complaint of wound discharge and mild pain. Blood
tests were normal except for CRP and ESR levels which were
high (5 mg/dL and 96 mm/1st hour, respectively). Wound debride-
ment and antibiotic beads insertion (Gentamycin + Piperacillin-
Tazobactam + Ceftriaxone) was done after taking infectious disease
team on board. Intraoperative Cultures were chased and Aeromonas
Hydrophila was  found in the wound.
Daily dressing of the wound and administration of Intravenous
ceftriaxone antibiotic for 7 days helped in proper healing of the
wound. Follow up after 1 week was satisfactory, the wound was
clean with healthy granulation tissue and the thigh wound had
healed with satisfactory radiographs (Fig. 1). She was using elbow
crutch with weight bearing as tolerated.
Clinical and radiological union at fracture site was  achieved after
3 months (Fig. 2) and patient was back to her usual status of health
before sustaining the fracture. On her last follow-up, around 2 years
postoperatively, she was full weight-bearing with healed scars. No
issues were seen at the bone graft donor site and antibiotic beads
were still in place. Taking into consideration her surgical risk, we
planned not to remove the beads.
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Fig. 2. X-ray of the right femur showing complete healing at fracture site 5 months postoperatively.
3. Discussion
This report is the ﬁrst description, to our knowledge, of a bone
graft donor site infection caused by a rare organism, A. hydrophila.
All Aeromonas isolates were resistant to amoxicillin but extended-
spectrum beta-lactam and ﬂuoroquinolone were active against
more than 95%.
Aeromonas hydrophila is a heterotrophic, motile, gram-negative,
rod-shaped bacterium mainly found in areas with a warm climate
and in water sources. Grown on cefsulodin-irgasan-novobiocin
(CIN) agar, being both oxidase and indole positive helps in its lab-
oratory identiﬁcation. It causes a wide range of human illness,
including intestinal and extra-intestinal diseases and syndromes,
ranging from systemic and local infections in both immunocom-
petent and immunocompromised hosts [1]. For example, acute
gastroenteritis, hepatobiliary tract infections, peritonitis, soft tissue
infections, meningitis, pneumonia, empyema, and primary sep-
ticemia [1,7,12]. It has also been implicated as a cause of cholangitis,
septic arthritis, osteomyelitis, myositis, ocular infections, urinary
tract infections, and hemolytic uremic syndrome [1,13].
Among these, the three most common human infections caused
by Aeromonas species are gastrointestinal infection, skin and
soft-tissue infection, and bacteremia in immunocompromised indi-
viduals [1,12].
Transmission of A. Hydrophila usually occurs through con-
sumption of contaminated food or by exposure of wounds to an
environment inhabited by the pathogen. Usually people suffering
from chronic illness, such as cirrhosis, malignancy, recent trauma,
hepatobiliary and pancreatic diseases, chronic renal failure, dia-
betes mellitus, or steroid use, get severe soft tissue infections
caused by A. Hydrophila [12].
Fatality rates in cases of bacteremia range from 28% to 46%
often caused by Aeromonas hydrophila and Aeromonas veronii biovar
sobria, most Aeromonas infections being polymicrobial [13,14].
The main mechanism of tissue damage A. hydrophila possesses
is a gene called Aerolysin Cytotoxic Enterotoxin (ACT) that releases
a toxin. The aerolysin toxin is an extracellular, soluble, hydrophilic
protein that exhibits both hemolytic and cytolytic properties, and
is produced by some strains of A. Hydrophila.  It binds to speciﬁc
glycoprotein receptors on eukaryotic cell surfaces allowing it to
insert into the lipid bilayer and form holes [15].
In reviewing literature and a few case reports from around the
globe, interestingly most reported fever as the primary clinical pre-
sentation in the ﬁrst 2 days following inoculation [10,16]. In our
case the patient did not develop fever and only presented with
wound discharge, which was sterile on culture sensitivity exam-
ination.
In orthopedic procedures, especially where implants are used,
this organism is encountered rarely. Very few case reports men-
tioned this as the primary pathogen found responsible for delayed
or chronic osteomyelitis in patients after open reduction and inter-
nal ﬁxation for open fractures. They emphasized on the rule of
multidisciplinary approach in managing these cases. Water/marine
exposure and imunocompromised status were among risk factors,
but not necessary [17–19]. This organism was  also reported to cause
bone and soft tissue infections even in healthy immunocompetent
individuals without water exposure [20].
Early surgical intervention is essential in saving the life of
patients with Aeromonas septicemia with deep soft tissue infec-
tion. Certain reports also point that delays in surgical removal of
necrotic tissue have resulted in high mortality [21]. In our case we
were working with the infection disease team from day 1. That
helped in early advice for reoperation and the decision of antibiotic
beads.
Another key concern regarding Aeromonas infections is their
resistance to antibiotics such as Penicillin, Ampicillin, Carbeni-
cillin and Cefazolin [22]. Thus, standard empirical therapies, that
are effective against streptococcal or staphylococcal soft tissue
infections, do not provide coverage for Aeromonas infection. The
organism is usually found to be susceptible to broad spectrum
cephalosporins, aminoglycosides, carbapenems, chloramphenicol,
trimethoprim – sulfamethoxazole and quinolones [15].
4. Conclusion
This case report shows rare infection of donor bone graft site by
a A. hydrophila in an immunocompromised patient due to multi-
ple comorbids. Symptoms of disease progression may  vary in such
patients. Soft tissue infection may  rapidly progress to fatal sepsis.
Early identiﬁcation and proper surgical intervention, along with
appropriate antibiotic therapy, lead to better outcome. A multidis-
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